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2• To ensure that a minimal set of measures, relevant to 
human spaceflight risks, is consistently captured from 
crewmembers until the end of the ISS
• The data from these measures will be placed in an 
archive managed by HRP and made available to 
studies via data sharing agreements
• Spaceflight Standard Measures will constitute a 
database for:
– Providing context for data acquired by concurrent 
experiments
– Supporting or developing hypotheses
– Evaluating the effectiveness of various in-flight 
countermeasure profiles 
– Comparing population responses to various mission 
durations (6 weeks, 6 months, 1 year) 
Objectives
3HRP Identified Risks
Risks addressed by the Spaceflight Standard Measures project
Altered Gravity Level
• Vision alterations
• Renal stone formation
• Sensorimotor alterations
• Bone fracture
• Reduced muscle mass, 
strength
• Reduced aerobic capacity
• Adverse host-
microorganism interactions
• Urinary retention
• Orthostatic intolerance
• Back pain
• Cardiac rhythm problems
Radiation
• Exposure to space 
radiation
Distance from Earth
• Limited in-flight 
medical capabilities
• Toxic medications
Isolation
• Adverse cognitive or 
behavioral conditions
• Performance & 
behavioral health 
decrements
Environment–Spacecraft 
Design
• Inadequate food/nutrition
• Human-system interaction
• Injury from dynamic loads
• Injury during EVA
• Celestial dust exposure
• Altered immune response
• Hypobaric hypoxia
• Sleep loss & work overload
• Decompression sickness
• Toxic exposure
• Hearing loss
• Sunlight exposure
4Experiment Design Overview
6-month mission
Pre-flight In-flight Post-flight
Actigraphy w/ sleep logs (2 
weeks each) (L-180, L-90) Actigraphy (continuous)
Actigraphy w/ sleep logs (2 
weeks) (R+0)
Personality Survey  (anytime 
preflight)
Sleep Quality/Team Questionnaire 
(monthly) Cellular Profile Survey  (R+15)
Cognition (L-120 fam, L-90) Cognition (FD30 & R-30) Cognition (R+10, R+30)
Cellular Profile (ambient blood, 
saliva) (L-180, L-90)
Cellular Profile (ambient blood, 
saliva) 
(Early mission vehicle return, R-0)
Cellular Profile (ambient 
blood, saliva) (R+30)
Biochemical Markers (blood, 
urine) (L-180)
Biochemical Markers (blood only)  
(FD30, R-30)
Biochemical Markers (blood, 
urine) (R+30)
Microbiome (body, saliva, 
fecal) (L-90)
Microbiome (body, saliva, fecal)
(FD30, R-30)
Microbiome (body, saliva, 
fecal) (R+30)
Carotid Intima-Media 
Thickness (cIMT)  (L-180) N/A
Carotid Intima-Media 
Thickness (cIMT)  (R+5, R+30)
Sensorimotor Measures  
(L-180 , L-90) N/A
Sensorimotor Measures 
(R+0 at landing site,                  
R+0 at JSC, R+9)
Crew time: 6.83 hrs Crew time: 15.25 hrs Crew time: 5.25 hrs
5Actigraphy
Actiwatch Spectrum 
• Wrist watch worn snug against the non-
dominant wrist
• Tracks movement and light data
Questionnaire
• A brief post-sleep survey daily when 
actigraphy is collected on the ground
Tests Sessions
• L-180, L-90: worn for two 2-week sessions 
• FD1 to R-0: worn continuously
• R+0: worn for one 2-week session
Measures
• Activity level (per min) 
• Light exposure
6Actigraphy
7Personality Survey &                                 
Sleep Quality/Team Questionnaire
Personality Survey
• International Personality Item Pool, Neuroticism-
Extraversion-Openness (IPIP-NEO)
• Paper-based survey
Sleep Quality/Team Questionnaire
• Completed in DCT in-flight
Tests Sessions
• Personality Survey – anytime pre-flight 
• Sleep Quality/Team Questionnaire – monthly in-flight
Measures
• Sleep quantity and quality
• Mood
• Affect
• Team cohesion and performance
• Crew living/habitability
8Cognition
A battery of 10 neurocognitive tests that cover a range 
of cognitive domains relevant for spaceflight
Test Sessions
• L-120, L-90
• FD30, R-30
• R+10, R+30
Measures 
• Reaction time
• Learning
• Working memory 
• Abstraction 
• Spatial orientation
• Emotion recognition
• Abstract reasoning
• Visual tracking
• Risk decision making
• Attention
9Cellular Profile
Blood Sample
• 2 tubes totaling 10 mL per session  
• In-flight live blood cells quickly returned to ground 
Saliva Collection
• One saliva sample per session (salivette) 
• In-flight, stowed in MELFI 
Cellular Profile Survey (post-flight only)
• A questionnaire about experiences during flight such 
as allergies, rashes, infections and wound healing
Test Sessions
• L-180, L-90
• ~FD30, R-30: Undock of return vehicle
• R+30
Measures 
• Stress hormone levels
• Viral shedding
• Protein level
• Types of blood cells
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Biochemical Markers
Blood Sample
• Ground: 3 tubes totaling 15.7 mL; collected early morning
• In-flight: 2 tubes totaling 15 mL per session
Urine Collection
• Ground only
• 24-hour urine collection–shared with medical collection 
when feasible
Questionnaire
• Ground only
• Exercise log completed at time of sample collection
Test Sessions
• L-180
• FD30, R-30
• R+30
Measures 
• Complete blood count
• Comprehensive metabolic panel
• Comprehensive chemistry panel
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Biochemical Markers
Liver enzyme alanine aminotransferase (ALT) 
from SSM subjects compared to 64 astronauts 
(purple line; mean ± SD)
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Microbiome
Body Swabs
• Sample forearm, forehead, nostril, and             
control area using pre-moistened swabs
• Brief environment, health, and hygiene 
survey completed the day of body swab 
collection 
Saliva Collection
• Sample every day for 4 days (salivette)
Fecal Sampling 
• Ground: Human Stool Sampling Kit
• Flight: Swab to collect sample from WHC
Test Sessions
• L-90
• FD30, R-30
• R+30
Measures 
• Types and concentrations of                               
micro-organisms on the body
13
Carotid Intima-Media Thickness
Examination
• Ultrasound measure of 
carotid arterial wall 
thickness, which is an early 
indicator of vascular 
dysfunction (oxidative stress)
Questionnaire
• Short survey conducted 
during the test regarding 
exercise, diet, sleep
Test Sessions
• L-180
• R+5, R+30
Measures 
• Thickness of the intima and 
media, the two inner layers 
of the carotid artery
14
Sensorimotor Measures
Sit-to-Stand Test 
• Rise from a seated position  
• Remain stationary for 10 sec
Tandem Walk Test 
• Walk heel-to-toe with eyes open/closed
Recovery from Fall/Stand Test
• Rise from a prone position 
• Remain stationary for 3 min
Motion Sickness Questionnaire
Test Sessions
• L-180, L-90
• R+0 at landing site, R+0 at JSC, R+9
Measures
• Body kinematics
• Balance
• Heart rate
• Blood pressure
15
Sensorimotor Measures
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Biochemical Analytes
• Blood samples
– plasma allergy profile, plasma cytokine 
levels, VS cell expansion and cytotoxicity,      
T cell function, peripheral leukocyte 
distribution, and mitogen stimulated 
cytokine profiles, iCa, white blood cell count, 
neutrophils, lymphocytes, monocytes, 
eosinophils, basophils, red blood cell count, 
reticulocyte count, platelet count, mean 
platelet volume, and platelet distribution 
width
– serum CO2, BUN, bilirubin, glucose, serum 
1,25-dihydroxyvitamin D, serum 25-
hydroxyvitamin D, BSAP, calcium, ALT, AST, 
alkaline phosphatase, sodium, potassium, 
chloride, total protein, albumin, creatinine, 
osteocalcin, undercarboxylated osteocalcin, 
intact PTH, osteoprotegerin (OPG), 
osteoprotegerin ligand/RANKL, leptin, IGF-1, 
sclerostin, hepcidin, and N-terminal 
propeptide of type I procollagen (P1NP)
– hemoglobin, hematocrit
• Urine samples
– sodium, potassium, creatinine, 
pH, 24-hour volume, calcium, 
phosphorus, magnesium, uric 
acid, citrate, sulfate, calcium 
oxalate supersaturation, calcium 
phosphate supersaturation, 
sodium urate supersaturation, 
struvite supersaturation, uric 
acid supersaturation, and 
oxalate
• Saliva samples 
– viral DNA
• Body and fecal samples
– bacterial DNA (gDNA, 16S rDNA)
– microbial differences in 
community composition among 
group of samples
